T1	Age 2 13	58-year-old
T2	Personal_background 14 19	white
T3	Personal_background 20 28	American
T4	Sex 29 33	male
T5	Clinical_event 34 43	presented
E1	Clinical_event:T5 
T6	Nonbiological_location 51 71	emergency department
T7	Nonbiological_location 73 75	ED
R1	IDENTICAL Arg1:T7 Arg2:T6	
T8	Sign_symptom 97 106	confusion
E2	Sign_symptom:T8 
T9	Sign_symptom 108 122	disorientation
E3	Sign_symptom:T9 
T10	Sign_symptom 124 150	inability to walk steadily
E4	Sign_symptom:T10 
T11	Sign_symptom 156 167	dehydration
E5	Sign_symptom:T11 
T12	Sign_symptom 196 204	weakness
E6	Sign_symptom:T12 
T13	Sign_symptom 206 214	polyuria
E7	Sign_symptom:T13 
T14	Sign_symptom 220 230	polydipsia
E8	Sign_symptom:T14 
T15	Duration 231 253	over the previous week
E9	Duration:T15 
R2	MODIFY Arg1:E9 Arg2:E8	
R3	MODIFY Arg1:E9 Arg2:E7	
R4	MODIFY Arg1:E9 Arg2:E6	
T16	Detailed_description 82 93	acute onset
R5	MODIFY Arg1:T16 Arg2:E2	
R6	MODIFY Arg1:T16 Arg2:E3	
R7	MODIFY Arg1:T16 Arg2:E4	
R8	MODIFY Arg1:T16 Arg2:E5	
T17	Disease_disorder 282 285	CML
E10	Disease_disorder:T17 
#1	AnnotatorNotes E10	Chronic myeloid leukemia
T18	Date 286 303	six years earlier
E11	Date:T18 
T19	Clinical_event 267 276	diagnosed
E12	Clinical_event:T19 
T20	Medication 348 360	chemotherapy
E13	Medication:T20 
T21	Detailed_description 339 347	multiple
T22	Detailed_description 361 369	regimens
R9	MODIFY Arg1:T22 Arg2:E13	
R10	MODIFY Arg1:T21 Arg2:E13	
T23	Medication 409 420	allopurinol
E14	Medication:T23 
T24	Clinical_event 425 433	awaiting
E15	Clinical_event:T24 
T25	Therapeutic_procedure 444 466	bone marrow transplant
E16	Therapeutic_procedure:T25 
A1	POLARITY E16 NEG
#2	AnnotatorNotes E16	This event is Negative because it hadn't happened yet
T26	Detailed_description 434 443	allogenic
R11	MODIFY Arg1:T26 Arg2:E16	
R12	MODIFY Arg1:E16 Arg2:E15	
T27	Sign_symptom 313 335	hematological response
E17	Sign_symptom:T27 
A2	POLARITY E17 NEG
T28	Diagnostic_procedure 468 479	Vital signs
E18	Diagnostic_procedure:T28 
T29	Clinical_event 483 492	admission
E19	Clinical_event:T29 
T30	Nonbiological_location 500 502	ED
R13	MODIFY Arg1:T30 Arg2:E19	
T31	Diagnostic_procedure 512 522	heart rate
E20	Diagnostic_procedure:T31 
T32	Lab_value 526 533	104 bpm
R14	MODIFY Arg1:T32 Arg2:E20	
T33	Diagnostic_procedure 535 549	blood pressure
E21	Diagnostic_procedure:T33 
T34	Lab_value 553 565	122/68 mm Hg
R15	MODIFY Arg1:T34 Arg2:E21	
T35	Diagnostic_procedure 570 581	temperature
E22	Diagnostic_procedure:T35 
T36	Lab_value 585 591	99.7°F
T37	Lab_value 593 599	37.6°C
R16	MODIFY Arg1:T36 Arg2:E22	
R17	MODIFY Arg1:T37 Arg2:E22	
T38	Diagnostic_procedure 639 659	physical examination
E23	Diagnostic_procedure:T38 
T39	Lab_value 613 635	no remarkable findings
R18	MODIFY Arg1:T39 Arg2:E23	
T41	Sign_symptom 697 708	dehydration
E25	Sign_symptom:T41 
T40	Sign_symptom 671 692	altered mental status
E24	Sign_symptom:T40 
T42	Diagnostic_procedure 710 732	Laboratory evaluations
E26	Diagnostic_procedure:T42 
T43	Diagnostic_procedure 739 749	hemoglobin
E27	Diagnostic_procedure:T43 
T44	Lab_value 750 759	13.3 g/dL
R19	MODIFY Arg1:T44 Arg2:E27	
T45	Diagnostic_procedure 761 783	white blood cell count
E28	Diagnostic_procedure:T45 
T46	Lab_value 784 794	18.3×109/L
T47	Lab_value 796 813	neutrophils 79.6%
T48	Lab_value 815 831	lymphocytes 7.2%
T49	Lab_value 837 851	monocytes 8.3%
R20	MODIFY Arg1:T46 Arg2:E28	
R21	MODIFY Arg1:T47 Arg2:E28	
R22	MODIFY Arg1:T48 Arg2:E28	
R23	MODIFY Arg1:T49 Arg2:E28	
T50	Diagnostic_procedure 858 872	platelet count
E29	Diagnostic_procedure:T50 
T51	Lab_value 873 882	910×109/L
R24	MODIFY Arg1:T51 Arg2:E29	
T52	Diagnostic_procedure 884 896	Serum levels
E30	Diagnostic_procedure:T52 
R25	SUB_PROCEDURE Arg1:E27 Arg2:E26	
R26	SUB_PROCEDURE Arg1:E28 Arg2:E26	
R27	SUB_PROCEDURE Arg1:E29 Arg2:E26	
T53	Diagnostic_procedure 903 910	calcium
E31	Diagnostic_procedure:T53 
T54	Lab_value 911 921	18.6 mg/dL
R28	MODIFY Arg1:T54 Arg2:E31	
T55	Diagnostic_procedure 923 932	phosphate
E32	Diagnostic_procedure:T55 
T56	Lab_value 933 942	4.6 mg/dL
R29	MODIFY Arg1:T56 Arg2:E32	
T57	Diagnostic_procedure 944 950	sodium
E33	Diagnostic_procedure:T57 
T58	Lab_value 951 960	135 mEq/L
R30	MODIFY Arg1:T58 Arg2:E33	
T59	Diagnostic_procedure 962 971	potassium
E34	Diagnostic_procedure:T59 
T60	Lab_value 972 981	2.7 mg/dL
R31	MODIFY Arg1:T60 Arg2:E34	
T61	Diagnostic_procedure 983 990	albumin
E35	Diagnostic_procedure:T61 
T62	Lab_value 991 999	4.0 g/dL
R32	MODIFY Arg1:T62 Arg2:E35	
T63	Diagnostic_procedure 1001 1011	creatinine
E36	Diagnostic_procedure:T63 
T64	Lab_value 1012 1021	2.2 mg/dL
R33	MODIFY Arg1:T64 Arg2:E36	
T65	Diagnostic_procedure 1023 1038	total bilirubin
E37	Diagnostic_procedure:T65 
T66	Lab_value 1039 1048	0.9 mg/dL
R34	MODIFY Arg1:T66 Arg2:E37	
T67	Diagnostic_procedure 1050 1070	alkaline phosphatase
E38	Diagnostic_procedure:T67 
T68	Lab_value 1071 1079	125 IU/L
R35	MODIFY Arg1:T68 Arg2:E38	
T69	Diagnostic_procedure 1081 1107	aspartate aminotransferase
E39	Diagnostic_procedure:T69 
T70	Lab_value 1108 1115	41 IU/L
R36	MODIFY Arg1:T70 Arg2:E39	
T71	Diagnostic_procedure 1121 1145	alanine aminotransferase
E40	Diagnostic_procedure:T71 
T72	Lab_value 1146 1153	71 IU/L
R37	MODIFY Arg1:T72 Arg2:E40	
R38	SUB_PROCEDURE Arg1:E31 Arg2:E30	
R39	SUB_PROCEDURE Arg1:E32 Arg2:E30	
R40	SUB_PROCEDURE Arg1:E33 Arg2:E30	
R41	SUB_PROCEDURE Arg1:E34 Arg2:E30	
R42	SUB_PROCEDURE Arg1:E35 Arg2:E30	
R43	SUB_PROCEDURE Arg1:E36 Arg2:E30	
R44	SUB_PROCEDURE Arg1:E37 Arg2:E30	
R45	SUB_PROCEDURE Arg1:E38 Arg2:E30	
R46	SUB_PROCEDURE Arg1:E39 Arg2:E30	
R47	SUB_PROCEDURE Arg1:E40 Arg2:E30	
T73	Diagnostic_procedure 1155 1159	SPEP
E41	Diagnostic_procedure:T73 
#3	AnnotatorNotes E41	Serum protein electrophoresis
T74	Lab_value 1164 1187	negative for an M spike
R48	MODIFY Arg1:T74 Arg2:E41	
T75	Diagnostic_procedure 1189 1217	Hormones and vitamins levels
E42	Diagnostic_procedure:T75 
T76	Diagnostic_procedure 1224 1227	PTH
E43	Diagnostic_procedure:T76 
T77	Diagnostic_procedure 1251 1256	PHTrP
E44	Diagnostic_procedure:T77 
T78	Lab_value 1228 1236	8.5 pg/L
R49	MODIFY Arg1:T78 Arg2:E43	
T79	Lab_value 1257 1265	1.4 pg/L
R50	MODIFY Arg1:T79 Arg2:E44	
T80	Diagnostic_procedure 1277 1292	25-OH vitamin D
E45	Diagnostic_procedure:T80 
T81	Lab_value 1293 1303	30.4 ng/mL
R51	MODIFY Arg1:T81 Arg2:E45	
T82	Diagnostic_procedure 1322 1340	1,25 OH vitamin D3
E46	Diagnostic_procedure:T82 
T83	Lab_value 1341 1351	33.7 ng/mL
R52	MODIFY Arg1:T83 Arg2:E46	
T84	Diagnostic_procedure 1373 1380	CT scan
E47	Diagnostic_procedure:T84 
T85	Biological_structure 1367 1372	Chest
R53	MODIFY Arg1:T85 Arg2:E47	
T86	Sign_symptom 1402 1409	lesions
E48	Sign_symptom:T86 
T87	Detailed_description 1396 1401	lytic
T88	Detailed_description 1388 1395	diffuse
R54	MODIFY Arg1:T87 Arg2:E48	
R55	MODIFY Arg1:T88 Arg2:E48	
T89	Sign_symptom 1414 1430	bone destruction
E49	Sign_symptom:T89 
T90	Biological_structure 1457 1474	thoracic skeleton
R56	MODIFY Arg1:T90 Arg2:E49	
T91	Sign_symptom 1499 1522	bone marrow involvement
E50	Sign_symptom:T91 
A3	POLARITY E50 UNCERTAIN
T92	Sign_symptom 1641 1652	blast phase
E51	Sign_symptom:T92 
T93	Disease_disorder 1592 1595	CML
E52	Disease_disorder:T93 
T94	Sign_symptom 1607 1620	hypercalcemia
E53	Sign_symptom:T94 
T95	Therapeutic_procedure 1680 1689	hydration
E54	Therapeutic_procedure:T95 
T96	Detailed_description 1669 1679	aggressive
R57	MODIFY Arg1:T96 Arg2:E54	
T97	Medication 1700 1706	saline
E55	Medication:T97 
T98	Medication 1711 1721	calcitonin
E56	Medication:T98 
T99	Lab_value 1695 1699	0.9%
R58	MODIFY Arg1:T99 Arg2:E55	
T100	Dosage 1722 1731	400 units
T101	Administration 1732 1744	subcutaneous
R59	MODIFY Arg1:T100 Arg2:E56	
R60	MODIFY Arg1:T101 Arg2:E56	
T102	Medication 1777 1792	zoledronic acid
E57	Medication:T102 
T103	Dosage 1793 1799	3.3 mg
R61	MODIFY Arg1:T103 Arg2:E57	
T104	Administration 1800 1811	intravenous
R62	MODIFY Arg1:T104 Arg2:E57	
T105	Detailed_description 1813 1845	adjusted for renal insufficiency
R63	MODIFY Arg1:T105 Arg2:E57	
T106	Duration 1858 1873	After five days
E58	Duration:T106 
T107	Sign_symptom 1905 1913	symptoms
E59	Sign_symptom:T107 
A4	POLARITY E59 NEG
T108	Diagnostic_procedure 1918 1938	serum calcium levels
E60	Diagnostic_procedure:T108 
T109	Lab_value 1888 1901	normalization
R64	MODIFY Arg1:T109 Arg2:E60	
T110	Clinical_event 1960 1969	discharge
E61	Clinical_event:T110 
T111	Nonbiological_location 1979 1987	hospital
R65	MODIFY Arg1:T111 Arg2:E61	
T112	Therapeutic_procedure 2016 2036	palliative treatment
E62	Therapeutic_procedure:T112 
T113	Medication 2042 2051	ponatinib
E63	Medication:T113 
T114	Therapeutic_procedure 2056 2068	radiotherapy
E64	Therapeutic_procedure:T114 
R66	SUB_PROCEDURE Arg1:E63 Arg2:E62	
R67	SUB_PROCEDURE Arg1:E64 Arg2:E62	
T115	Diagnostic_procedure 2081 2101	serum calcium levels
E65	Diagnostic_procedure:T115 
T116	Lab_value 2107 2117	maintained
R68	MODIFY Arg1:T116 Arg2:E65	
T117	Medication 2123 2138	zoledronic acid
E66	Medication:T117 
T118	Dosage 2139 2161	4 mg every eight weeks
R69	MODIFY Arg1:T118 Arg2:E66	
T119	Disease_disorder 2192 2198	cancer
E67	Disease_disorder:T119 
A5	TREND E67 INC
T120	Outcome 2217 2228	passed away
E68	Outcome:T120 
T121	Date 2243 2261	eight months after
E69	Date:T121 
*	OVERLAP E1 E2 E3 E4 E5
R70	AFTER Arg1:E5 Arg2:E6	
*	OVERLAP E6 E7 E8 E9
R71	AFTER Arg1:E9 Arg2:E12	
*	OVERLAP E12 E10 E11 E17 E13
R72	BEFORE Arg1:E13 Arg2:E14	
*	OVERLAP E14 E15 E16
R73	BEFORE Arg1:E16 Arg2:E18	
*	OVERLAP E18 E19 E20 E21 E22 E23 E24 E25 E26 E30 E41 E42 E47 E48 E49 E50
R74	SUB_PROCEDURE Arg1:E43 Arg2:E42	
R75	SUB_PROCEDURE Arg1:E44 Arg2:E42	
R76	SUB_PROCEDURE Arg1:E45 Arg2:E42	
R77	SUB_PROCEDURE Arg1:E46 Arg2:E42	
T122	Clinical_event 1579 1588	diagnosis
E70	Clinical_event:T122 
R78	BEFORE Arg1:E50 Arg2:E70	
*	OVERLAP E70 E52 E53 E51
R79	BEFORE Arg1:E51 Arg2:E54	
R80	SUB_PROCEDURE Arg1:E55 Arg2:E54	
R81	SUB_PROCEDURE Arg1:E56 Arg2:E54	
*	OVERLAP E54 E57
R82	BEFORE Arg1:E57 Arg2:E58	
*	OVERLAP E58 E59 E60
R83	BEFORE Arg1:E60 Arg2:E61	
R84	BEFORE Arg1:E61 Arg2:E62	
*	OVERLAP E62 E65 E66
R85	BEFORE Arg1:E66 Arg2:E67	
R86	BEFORE Arg1:E67 Arg2:E68	
*	OVERLAP E68 E69
